McKesson Prescription Technology Solutions — Total other segment expense, net increased by 9.5% to $1.24B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 7.6%, from $1.15B to $1.24B. Over 2 years (FY 2023 to FY 2025), Prescription Technology Solutions — Total other segment expense, net shows an upward trend with a 6.6% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase relative to revenue may signal declining operational efficiency or rising overhead costs.
This metric reflects the net total of miscellaneous expenses incurred by the Prescription Technology Solutions segment t...
Comparable to 'unallocated corporate expenses' or 'other segment operating costs' at peer companies.
mck_segment_prescription_technology_solutions_total_other_segment_expense_net| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $955.25M | $955.25M | $955.25M | $955.25M | $684.00M | $1.04B | $1.06B | $1.15B | $789.00M | $1.18B | $1.13B | $1.24B |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -28.4% | +51.8% | +2.1% | +8.7% | -31.5% | +49.7% | -4.1% | +9.5% |
| YoY Change | — | — | — | — | -28.4% | +8.7% | +11.0% | +20.6% | +15.4% | +13.8% | +6.8% | +7.6% |